Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin-Reference-Cited by-同舟云学术

Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin

Published:2015-07-19 Issue:2 Volume:7 Page:253-259
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Kawamori Ryuzo¹,Kaku Kohei²,Hanafusa Toshiaki³,Ioriya Katsuhisa⁴,Kageyama Shigeru⁵,Hotta Nigishi⁶

Affiliation:

1. Sportology Center Juntendo University Graduate School of Medicine Tokyo Japan

2. Department of General Internal Medicine 1 Kawasaki Medical School Kurashiki Japan

3. Department of Internal Medicine (I) Osaka Medical College Takatsuki Japan

4. Sumitomo Dainippon Pharma Co., Ltd. Tokyo Japan

5. Clinical Research Support Center The Jikei University School of Medicine Tokyo Japan

6. Labor, Health and Welfare Organization Chubu‐Rosai Hospital Nagoya Japan

Funder

Sumitomo Dainippon Pharma Co., Ltd.

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12384

Reference20 articles.

1. Japan Diabetes Society.Evidence‐based practice guideline for the treatment of diabetes in Japan 2013. Tokyo Japan (in Japanese).

2. Diagnosis and Classification of Diabetes Mellitus

3. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parallel artificial liquid membrane extraction coupled with UPLC-ESI-MS/MS method for high-throughput quantitation of repaglinide in diabetic patients;Talanta;2024-03

2. Antidiabetic and neuroprotective effects of a novel repaglinide analog;Journal of Biochemical and Molecular Toxicology;2022-06-15

3. Efficacy and Cardiovascular Safety of Meglitinides;Current Drug Safety;2021-06-08

4. Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F);Diabetology International;2020-02-14

5. Characteristics of repaglinide effects on insulin secretion;European Journal of Pharmacology;2018-06